Skip to main navigation Skip to search Skip to main content

DLK1, a serum marker for hepatoblastoma in young infants.

  • F.A. Falix
  • , D.C. Aronson
  • , W.H. Lamers
  • , J.K. Hiralall
  • , J. Seppen*
  • *Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

Hepatoblastoma is a malignant pediatric liver tumor. The currently used diagnostic serum marker for hepatoblastoma, a-fetoprotein (AFP), is not always reliable in infants with hepatoblastoma, due to the physiologically elevated levels of AFP in this age group. In this report, we show that Delta-like 1 homolog (DLK1), a protein highly expressed during fetal development, but almost completely absent after birth, and an established liver-stem cell marker, is a new candidate serum marker of hepatoblastoma, especially in young infants. Pediatr Blood Cancer 2012;59:743745. (c) 2011 Wiley Periodicals, Inc.

Original languageEnglish
Pages (from-to)743-745
Number of pages3
JournalPediatric Blood & Cancer
Volume59
Issue number4
DOIs
Publication statusPublished - Oct 2012

Keywords

  • DLK1
  • hepatoblastoma
  • serum marker
  • CHILDHOOD HEPATOBLASTOMA
  • LIVER-TUMORS
  • PROTEIN DLK
  • EXPRESSION
  • CHILDREN

Fingerprint

Dive into the research topics of 'DLK1, a serum marker for hepatoblastoma in young infants.'. Together they form a unique fingerprint.

Cite this